Outpatient Parenteral Antimicrobial Therapy Practices among Adult Infectious Disease Physicians

Lane, Michael A; Marschall, Jonas; Beekmann, Susan E; Polgreen, Philip M; Banerjee, Ritu; Hersh, Adam L; Babcock, Hilary M (2014). Outpatient Parenteral Antimicrobial Therapy Practices among Adult Infectious Disease Physicians. Infection control and hospital epidemiology, 35(7), pp. 839-844. University of Chicago Press 10.1086/676859

[img]
Preview
Text
676859.pdf - Published Version
Available under License Publisher holds Copyright.

Download (307kB) | Preview

Objective. To identify current outpatient parenteral antibiotic therapy practice patterns and complications. Methods. We administered an 11-question survey to adult infectious disease physicians participating in the Emerging Infections Network (EIN), a Centers for Disease Control and Prevention-sponsored sentinel event surveillance network in North America. The survey was distributed electronically or via facsimile in November and December 2012. Respondent demographic characteristics were obtained from EIN enrollment data. Results. Overall, 555 (44.6%) of EIN members responded to the survey, with 450 (81%) indicating that they treated 1 or more patients with outpatient parenteral antimicrobial therapy (OPAT) during an average month. Infectious diseases consultation was reported to be required for a patient to be discharged with OPAT by 99 respondents (22%). Inpatient (282 [63%] of 449) and outpatient (232 [52%] of 449) infectious diseases physicians were frequently identified as being responsible for monitoring laboratory results. Only 26% (118 of 448) had dedicated OPAT teams at their clinical site. Few infectious diseases physicians have systems to track errors, adverse events, or "near misses" associated with OPAT (97 [22%] of 449). OPAT-associated complications were perceived to be rare. Among respondents, 80% reported line occlusion or clotting as the most common complication (occurring in 6% of patients or more), followed by nephrotoxicity and rash (each reported by 61%). Weekly laboratory monitoring of patients who received vancomycin was reported by 77% of respondents (343 of 445), whereas 19% of respondents (84 of 445) reported twice weekly laboratory monitoring for these patients. Conclusions. Although use of OPAT is common, there is significant variation in practice patterns. More uniform OPAT practices may enhance patient safety.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Marschall, Jonas

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0899-823X

Publisher:

University of Chicago Press

Language:

English

Submitter:

Annelies Luginbühl

Date Deposited:

13 Oct 2014 11:35

Last Modified:

31 Aug 2015 02:30

Publisher DOI:

10.1086/676859

PubMed ID:

24915212

BORIS DOI:

10.7892/boris.53856

URI:

https://boris.unibe.ch/id/eprint/53856

Actions (login required)

Edit item Edit item
Provide Feedback